Epigenetics Diagnostic Market by Product (Reagents, Kits, Instruments, Enzymes, and Services); By Technology (DNA Methylation, Histone Methylation, Histone Acetylation, MicroRNA Modification, Large Non-Coding RNA, and Chromatin Structure); By Application (Oncology, and Non-Oncology); By Geography (North America, Asia-Pacific, Europe, South America, and RoW), Industry Trends, Estimation & Forecast, 2018 – 2026

Market Overview

The Global Epigenetics Diagnostic market is estimated to reach $22.5 billion by 2026, with a projected CAGR of 16.2% during the forecast period. Epigenetics diagnostic refers to the analysis of gene expression of humans. Epigenetics diagnostics have emerged as a useful measure for treatment of chronic diseases such as cancer.

Market Dynamics

Increasing prevalence of chronic and genetic diseases across the globe, and growing geriatric population are the major factors driving the growth of the global epigenetics diagnostic market. In addition, increasing governmental support for research and development of epigenetics reagents in order to cure several fatal and deadly diseases in humans is expected to further drive the market throughout the forecast period. Moreover, many biotechnology and pharmaceutical companies and academic research organizations are working together to promote the growth of the diagnostic industry of epigenetics is likely to gain significant impetus for the epigenetics diagnostic market share in the coming years.

Market Segmentation

The global epigenetics diagnostic market is segmented based on the product, technology, application, and geography. The product segment includes reagents, kits, instruments, enzymes, and services. By technology segment, the segmentation comprises of DNA methylation, histone methylation, histone acetylation, microRNA modification, large non-coding RNA, and chromatin structure. Oncology, non-oncology are the classification of the Application segment. Furthermore, geographical coverage has been offered for each of the major regions including North America, Asia-Pacific, Europe, Row, and South America.

Scope of the Global Epigenetics Diagnostic Market

By Product

• Reagents
• Kits
  • Chip Sequencing Kit
  • Whole Genomic Amplification Kit
  • Bisulfite Conversion Kit
  • RNA Sequencing Kit
  • Others
• Instruments
• Enzymes
• Services

By Technology

• DNA Methylation
• Histone Methylation
• Histone Acetylation
• MicroRNA Modification
• Large Non-Coding RNA
• Chromatin Structure

By Application

• Oncology
  • Solid Tumors
  • Liquid Tumors
• Non-Oncology
  • Metabolic Diseases
  • Inflammatory Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Others

By Geography

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Korea
  • Rest of APAC
• South America
  • Brazil
  • Rest of South America
• Rest of the World
  • Middle East
  • Africa

TABLE OF CONTENTS

Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Market Scope

Chapter 2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources

Chapter 3 Market Overview
3.1 Report Segmentation & Scope
3.2 Key Market Trends
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.3 Porter’s Five Forces Analysis
3.4 Market Share Analysis

Chapter 4 Global Epigenetics Diagnostic Market by Product: Market Size and Forecast, 2018 – 2026
4.1 Introduction
4.1.1 Market Size and Forecast
4.2 Reagents
4.2.1 Market Size and Forecast
4.3 Kits
4.3.1 Market Size and Forecast
4.3.2 Chip Sequencing Kit
4.3.2.1 Market Size and Forecast
4.3.3 Whole Genomic Amplification Kit
4.3.3.1 Market Size and Forecast
4.3.4 Bisulfite Conversion Kit
4.3.4.1 Market Size and Forecast
4.3.5 RNA Sequencing Kit
4.3.5.1 Market Size and Forecast
4.3.6 Others
4.3.6.1 Market Size and Forecast
4.4 Instruments
4.4.1 Market Size and Forecast
4.5 Enzymes
4.5.1 Market Size and Forecast
4.6 Services
4.6.1 Market Size and Forecast

Chapter 5 Global Epigenetics Diagnostic Market by Technology: Market Size and Forecast, 2018 – 2026
5.1 Introduction
5.1.1 Market Size and Forecast
5.2 DNA Methylation
5.2.1 Market Size and Forecast
5.3 Histone Methylation
5.3.1 Market Size and Forecast
5.4 Histone Acetylation
5.4.1 Market Size and Forecast
5.5 MicoRNA Modification
5.5.1 Market Size and Forecast
5.6 Large Non-Coding RNA
5.6.1 Market Size and Forecast
5.7 Chromatin Structure
5.7.1 Market Size and Forecast

Chapter 6 Global Epigenetics Diagnostic Market by Application: Market Size and Forecast, 2018 – 2026
6.1 Introduction
6.1.1 Market Size and Forecast
6.2 Oncology
6.2.1 Market Size and Forecast
6.2.2 Solid Tumors
6.2.2.1 Market Size and Forecast
6.2.3 Liquid Tumors
6.2.3.1 Market Size and Forecast
6.3 Non-Oncology
6.3.1 Market Size and Forecast
6.3.2 Metabolic Diseases
6.3.2.1 Market Size and Forecast
6.3.3 Inflammatory Diseases
6.3.3.1 Market Size and Forecast
6.3.4 Cardiovascular Diseases
6.3.4.1 Market Size and Forecast
6.3.5 Infectious Diseases
6.3.5.1 Market Size and Forecast
6.3.6 Others
6.3.6.1 Market Size and Forecast

Chapter 7 Global Epigenetics Diagnostic Market by Geography: Market Size and Forecast, 2018 – 2026
7.1 Introduction
7.1.1 Market Size and Forecast
7.2 North America
7.2.1 North America Market Size & Forecast, By Country
7.2.2 North America Market Size & Forecast, By Product
7.2.3 North America Market Size & Forecast, By Technology
7.2.4 North America Market Size & Forecast, By Application
7.2.5 The U.S.
7.2.5.1 Market Size and Forecast
7.2.6 Canada
7.2.6.1 Market Size and Forecast
7.2.7 Mexico
7.2.7.1 Market Size and Forecast
7.3 Europe
7.3.1 Europe Market Size and Forecast, By Country
7.3.2 Europe Market Size and Forecast, By Product
7.3.3 Europe Market Size and Forecast, By Technology
7.3.4 Europe Market Size and Forecast, By Application
7.3.5 UK
7.3.5.1 Market Size and Forecast
7.3.6 Germany
7.3.6.1 Market Size and Forecast
7.3.7 France
7.3.7.1 Market Size and Forecast
7.3.8 Italy
7.3.8.1 Market Size and Forecast
7.3.9 Spain
7.3.9.1 Market Size and Forecast
7.3.10 Rest of Europe
7.3.10.1 Market Size and Forecast
7.4 Asia-Pacific
7.4.1 Asia-Pacific Market Size and Forecast, By Country
7.4.2 Asia-Pacific Market Size and Forecast, By Product
7.4.3 Asia-Pacific Market Size and Forecast, By Technology
7.4.4 Asia-Pacific Market Size and Forecast, By Application
7.4.5 India
7.4.5.1 Market Size and Forecast
7.4.6 China
7.4.6.1 Market Size and Forecast
7.4.7 Australia
7.4.7.1 Market Size and Forecast
7.4.8 Japan
7.4.8.1 Market Size and Forecast
7.4.9 South Korea
7.4.9.1 Market Size and Forecast
7.4.10 Rest of Asia-Pacific
7.4.10.1 Market Size and Forecast
7.5 South America
7.5.1 South America Market Size and Forecast, By Country
7.5.2 South America Market Size and Forecast, By Product
7.5.3 South America Market Size and Forecast, By Technology
7.5.4 South America Market Size and Forecast, By Application
7.5.5 Brazil
7.5.5.1 Market Size and Forecast
7.5.6 Rest of South America
7.5.6.1 Market Size and Forecast
7.6 RoW
7.6.1 RoW Market Size and Forecast, By Country
7.6.2 RoW Market Size and Forecast, By Product
7.6.3 RoW Market Size and Forecast, By Technology
7.6.4 RoW Market Size and Forecast, By Application
7.6.5 Middle East
7.6.5.1 Market Size and Forecast
7.6.6 Africa
7.6.6.1 Market Size and Forecast

Chapter 8 Company Profiles
8.1 Diagenode Diagnostics
8.2 Eisai Co. Ltd.
8.3 EpiGen
8.4 Illumina, Inc.
8.5 Novartis AG
8.6 Oncolys Biopharma Inc.
8.7 Qiagen
8.8 Roche Diagnostics
8.9 Sigma-Aldrich Corporation
8.10 Thermo Fisher Scientific, Inc.
8.11 Valirx Plc
8.12 Zymo Research Corporation

Epigenetics Diagnostic Market Key Players

• Diagenode Diagnostics
• Eisai Co. Ltd.
• EpiGen
• Illumina, Inc.
• Novartis AG
• Oncolys Biopharma Inc.
• Qiagen
• Roche Diagnostics
• Sigma-Aldrich Corporation
• Thermo Fisher Scientific, Inc.
• Valirx Plc
• Zymo Research Corporation